Mortality and length of stay associated with antimicrobial-susceptible and -resistant hospital-onset bloodstream infections at a tertiary referral hospital in Melbourne, Australia
| dc.contributor.author | Curtis S.J. | |
| dc.contributor.author | Lee S.J. | |
| dc.contributor.author | Cooper B.S. | |
| dc.contributor.author | Bell J.M. | |
| dc.contributor.author | Coombs G.W. | |
| dc.contributor.author | Daley D.A. | |
| dc.contributor.author | Cheng A.C. | |
| dc.contributor.author | Spelman D.W. | |
| dc.contributor.author | Peleg A.Y. | |
| dc.contributor.author | Stewardson A.J. | |
| dc.contributor.correspondence | Curtis S.J. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2025-10-31T18:23:53Z | |
| dc.date.available | 2025-10-31T18:23:53Z | |
| dc.date.issued | 2025-10-01 | |
| dc.description.abstract | Background and objectives: There are few Australian data regarding the burden of hospital-onset bloodstream infections (HO-BSIs). To quantify the impact of antimicrobial-susceptible and -resistant HO-BSIs on patient outcomes by augmenting laboratory-based surveillance data. Methods: We performed a retrospective cohort study at a tertiary referral hospital in Melbourne, Australia, from 2015 to 2020. We linked administrative data with bloodstream infection surveillance data from the Australian Group on Antimicrobial Resistance. We performed cause-specific Cox proportional hazards regression to quantify the impact of HO-BSI on inpatient mortality and discharge alive, with separate models for Enterobacterales, Staphylococcus aureus, Enterococcus species and the non-fermenting Gram-negative bacilli (NFGNB), Pseudomonas aeruginosa and Acinetobacter species, compared to admissions without HO-BSI. Excess length of stay (LOS) was estimated using multistate models. Results: The cohort of 278 984 admissions included 814 (0.3%) HO-BSIs. Enterobacterales were the most frequent pathogens, followed by enterococci, S. aureus and NFGNB (incidence 3.62, 2.34, 1.11 and 0.80 events per 10 000 patient-days, respectively). Both antimicrobial-resistant and -susceptible HO-BSI increased risk of death and LOS compared with admissions without HO-BSI. Antimicrobial-resistant and -susceptible HO-BSIs, respectively, increased LOS by 5.7 days (95% CI: 4.9–6.5) and 4.1 days (95% CI: 3.8–4.5) for Enterobacterales, 4.9 days (95% CI: 4.5–5.4) and 3.1 days (95% CI: 2.6–3.6) for enterococci, and 6.3 days (95% CI: 5.3–7.3) and 9.8 days (95% CI: 9.1–10.5) for S. aureus. Conclusions: Antimicrobial-susceptible and -resistant HO-BSIs have a substantial impact on patient outcomes. We demonstrated the feasibility of leveraging a national laboratory-based surveillance system to quantify the impact of HO-BSI. | |
| dc.identifier.citation | Jac Antimicrobial Resistance Vol.7 No.5 (2025) | |
| dc.identifier.doi | 10.1093/jacamr/dlaf183 | |
| dc.identifier.eissn | 26321823 | |
| dc.identifier.scopus | 2-s2.0-105019656641 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/112852 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Medicine | |
| dc.subject | Immunology and Microbiology | |
| dc.title | Mortality and length of stay associated with antimicrobial-susceptible and -resistant hospital-onset bloodstream infections at a tertiary referral hospital in Melbourne, Australia | |
| dc.type | Article | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105019656641&origin=inward | |
| oaire.citation.issue | 5 | |
| oaire.citation.title | Jac Antimicrobial Resistance | |
| oaire.citation.volume | 7 | |
| oairecerif.author.affiliation | Monash University | |
| oairecerif.author.affiliation | Murdoch University | |
| oairecerif.author.affiliation | Nuffield Department of Medicine | |
| oairecerif.author.affiliation | Monash Health | |
| oairecerif.author.affiliation | Fiona Stanley Hospital | |
| oairecerif.author.affiliation | Mahidol Oxford Tropical Medicine Research Unit | |
| oairecerif.author.affiliation | The Alfred | |
| oairecerif.author.affiliation | Australian Group on Antimicrobial Resistance |
